Cour Pharmaceuticals Raises $105M to Transform Autoimmune Treatmentby John Darbie 04.02.2024Cour Pharmaceuticals secures $105M in funding for revolutionary autoimmune disease treatments, using nanoparticle technology to reprogram the immune system. Transforming ...